lifestyle.forkstofeet.com

Avalyn to Highlight AURA-IPF Phase 2 Clinical Trial Design for AP02, Inhaled Nintedanib, at the European Respiratory Society International Congress 2025

Written by

Avalyn to Highlight AURA-IPF Phase 2 Clinical Trial Design for AP02, Inhaled Nintedanib, at the European Respiratory Society International Congress 2025 – NEWSnet – News… as it used to be

More Press Releases

April 26, 2026

InventionHome® Inventor Creates Self-Contained Electric Generator for Emission-Free Power in Enclosed Environments

April 26, 2026

Law Firm’s IP Monday Blog Highlights Innovation, Protection and Strategy

April 26, 2026

2026 AI Advantage Bootcamp Draws Thousands of Enrollments in First 48 Hours Following Strong Student Reviews

April 26, 2026

Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System